RT @drdavidliew: Big one from plenary, new option in ANCA-associated vasculitis: avacopan (anti-C5a) vs prednisolone in
Tweet Content
Big one from plenary, new option in ANCA-associated vasculitis:
avacopan (anti-C5a) vs prednisolone in patients receiving CYC/RTX: non-inf at 26w, superior at 52w in the phase III ADVOCATE trial with reduction in steroid toxicity
Merkel, Jayne et al OP0011 #EULAR2020 @RheumNow
Show on Archive Page
On
Display in Search Results
On